HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Wang, Xiangwei ^a   Choi, Jeong Hyeon ^b   Ding, Jane ^b   Yang, Liqun ^c   Ngoka, Lambert C ^b   Lee, Eun J ^b   Zha, Yunhong ^d   Mao, Ling ^e   Jin, Bilian ^b   Ren, Mingqiang ^b   Cowell, John ^b   Huang, Shuang ^b   Shi, Huidong ^b   Cui, Hongjuan ^c   Ding, Han Fei ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c SOUTHWEST UNIVERSITY   (China)

^d Three Gorges University College of Medicine   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell cycle arrest; DNA damage response; E2F6; HOXC9; Neuroblastoma; Neuronal differentiation

Indexed keywords

DNA; HOX PROTEIN; HOXC9 PROTEIN; TRANSCRIPTION FACTOR E2F6; UNCLASSIFIED DRUG; E2F6 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HOXC9 PROTEIN, HUMAN; PROTEIN BINDING; TRANSCRIPTOME;

ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL CYCLE PROGRESSION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; GEL PERMEATION CHROMATOGRAPHY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC ANALYSIS; HOX GENE; HOXC9 GENE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PROTEIN INTERACTION; TANDEM MASS SPECTROMETRY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; BINDING SITE; CELL DIFFERENTIATION; DNA SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HUMAN GENOME; METABOLISM; NERVE CELL; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BINDING SITES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA REPAIR; E2F6 TRANSCRIPTION FACTOR; GENE SILENCING; GENOME, HUMAN; HOMEODOMAIN PROTEINS; HUMANS; NEURONS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 84888096972     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-830     Document Type: Article

References (70)

1. Nouspikel T, Hanawalt PC. DNA repair in terminally differentiated cells. DNA Repair (Amst) 2002, 1(1):59-75. 10.1016/S1568-7864(01)00005-2, 12509297.
2. Simonatto M, Latella L, Puri PL. DNA damage and cellular differentiation: more questions than responses. J Cell Physiol 2007, 213(3):642-648. 10.1002/jcp.21275, 17894406.
3. Fortini P, Dogliotti E. Mechanisms of dealing with DNA damage in terminally differentiated cells. Mutat Res 2010, 685(1-2):38-44.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111. 10.1038/35102167, 11689955.
5. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006, 66(19):9339-9344. 10.1158/0008-5472.CAN-06-3126, 16990346.
6. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8(10):755-768. 10.1038/nrc2499, 18784658.
7. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444(7120):756-760. 10.1038/nature05236, 17051156.
8. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006, 98(24):1777-1785. 10.1093/jnci/djj495, 17179479.
9. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13(7):1238-1241. 10.1038/sj.cdd.4401872, 16456578.
10. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006, 5:67. 10.1186/1476-4598-5-67, 1697823, 17140455.
11. Pearson JC, Lemons D, McGinnis W. Modulating Hox gene functions during animal body patterning. Nat Rev Genet 2005, 6(12):893-904. 10.1038/nrg1726, 16341070.
12. Moens CB, Selleri L. Hox cofactors in vertebrate development. Dev Biol 2006, 291(2):193-206. 10.1016/j.ydbio.2005.10.032, 16515781.
13. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010, 10(5):361-371. 10.1038/nrc2826, 20357775.
14. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26(47):6766-6776. 10.1038/sj.onc.1210760, 17934484.
15. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003, 3:203-216. 10.1038/nrc1014, 12612655.
16. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010, 362(23):2202-2211. 10.1056/NEJMra0804577, 3306838, 20558371.
17. Kocak H, Ackermann S, Hero B, Kahlert Y, Oberthuer A, Juraeva D, Roels F, Theissen J, Westermann F, Deubzer H, et al. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death Dis 2013, 4:e586. 10.1038/cddis.2013.84, 3668636, 23579273.
18. Mao L, Ding J, Zha Y, Yang L, McCarthy BA, King W, Cui H, Ding HF. HOXC9 Links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma. Cancer Res 2011, 71(12):4314-4324. 10.1158/0008-5472.CAN-11-0051, 3116998, 21507931.
19. Seeds NW, Gilman AG, Amano T, Nirenberg MW. Regulation of axon formation by clonal lines of a neural tumor. Proc Natl Acad Sci USA 1970, 66(1):160-167. 10.1073/pnas.66.1.160, 286102, 5273894.
20. Jensen L, Linn S. A reduced rate of bulky DNA adduct removal is coincident with differentiation of human neuroblastoma cells induced by nerve growth factor. Mol Cell Biol 1988, 8(9):3964-3968. 365460, 3146694.
21. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982, 68(4):589-596.
22. Abemayor E, Sidell N. Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspect 1989, 80:3-15. 1567609, 2538324.
23. Zha Y, Ding E, Yang L, Mao L, Wang X, McCarthy BA, Huang S, Ding HF. Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation. PLoS One 2012, 7(8):e40728. 10.1371/journal.pone.0040728, 3413684, 22879880.
24. Byfield JE, Lee YC, Klisak I, Finklestein JZ. Effect of differentiation on the repair of DNA single strand breaks in neuroblastoma cells. Biochem Biophys Res Commun 1975, 63(3):730-735. 10.1016/S0006-291X(75)80444-X, 1169064.
25. McCombe P, Lavin M, Kidson C. Control of DNA repair linked to neuroblastoma differentiation. Int J Radiat Biol 1976, 29(6):523-531.
26. Lavin MF, McCombe P, Kidson C. DNA replication and post-replication repair in U.V.-sensitive mouse neuroblastoma cells. Int J Radiat Biol 1976, 30(1):31-40.
27. James M, Mansbridge J, Kidson C. Ultraviolet radiation sensitivity of proliferating and differentiated human neuroblastoma cells. Int J Radiat Biol 1982, 41(5):547-556.
28. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134(6):921-931. 10.1016/j.cell.2008.09.002, 2632951, 18805086.
29. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):3.
30. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2008, 4(1):44-57.
31. Francis NJ, Landis SC. Cellular and molecular determinants of sympathetic neuron development. Annu Rev Neurosci 1999, 22:541-566. 10.1146/annurev.neuro.22.1.541, 10202548.
32. Goridis C, Rohrer H. Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci 2002, 3(7):531-541.
33. Ernsberger U. The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neurons. Cell Tissue Res 2008, 333(3):353-371. 10.1007/s00441-008-0634-4, 2516536, 18629541.
34. Rajasekharan S, Kennedy T. The netrin protein family. Genome Biol 2009, 10(9):239. 10.1186/gb-2009-10-9-239, 2768972, 19785719.
35. Jung H, Lacombe J, Mazzoni EO, Liem KF, Grinstein J, Mahony S, Mukhopadhyay D, Gifford DK, Young RA, Anderson KV, et al. Global control of motor neuron topography mediated by the repressive actions of a single hox gene. Neuron 2010, 67(5):781-796. 10.1016/j.neuron.2010.08.008, 2955411, 20826310.
36. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002, 71(1):333-374. 10.1146/annurev.biochem.71.110601.135425, 12045100.
37. Carmena M, Wheelock M, Funabiki H, Earnshaw WC. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat Rev Mol Cell Biol 2012, 13(12):789-803. 10.1038/nrm3474, 3729939, 23175282.
38. Kee Y, D'Andrea AD. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 2010, 24(16):1680-1694. 10.1101/gad.1955310, 2922498, 20713514.
39. Liu Y, Kao H-I, Bambara RA. FLAP ENDONUCLEASE 1: a central component of DNA metabolism. Annu Rev Biochem 2004, 73(1):589-615. 10.1146/annurev.biochem.73.012803.092453, 15189154.
40. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002, 3(1):11-20.
41. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, Green R, Farnham PJ. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 2007, 17(11):1550-1561. 10.1101/gr.6783507, 2045138, 17908821.
42. Dasen JS, Liu JP, Jessell TM. Motor neuron columnar fate imposed by sequential phases of Hox-c activity. Nature 2003, 425(6961):926-933. 10.1038/nature02051, 14586461.
43. Rousso DL, Gaber ZB, Wellik D, Morrisey EE, Novitch BG. Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons. Neuron 2008, 59(2):226-240. 10.1016/j.neuron.2008.06.025, 2547125, 18667151.
44. Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell 2008, 134(2):304-316. 10.1016/j.cell.2008.06.019, 18662545.
45. Edlund T, Jessell TM. Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system. Cell 1999, 96(2):211-224. 10.1016/S0092-8674(00)80561-9, 9988216.
46. Ohnuma S, Harris WA. Neurogenesis and the cell cycle. Neuron 2003, 40(2):199-208. 10.1016/S0896-6273(03)00632-9, 14556704.
47. Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene 2003, 22(33):5208-5219. 10.1038/sj.onc.1206558, 12910258.
48. Salomoni P, Calegari F. Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol 2010, 20(5):233-243. 10.1016/j.tcb.2010.01.006, 20153966.
49. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13(12):1501-1512. 10.1101/gad.13.12.1501, 10385618.
50. Ohnuma S, Philpott A, Wang K, Holt CE, Harris WA. p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina. Cell 1999, 99(5):499-510. 10.1016/S0092-8674(00)81538-X, 10589678.
51. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 2006, 20(11):1511-1524. 10.1101/gad.377106, 1475763, 16705040.
52. Nieto M, Schuurmans C, Britz O, Guillemot F. Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors. Neuron 2001, 29(2):401-413. 10.1016/S0896-6273(01)00214-8, 11239431.
53. Sukhanova MJ, Deb DK, Gordon GM, Matakatsu MT, Du W. Proneural basic helix-loop-helix proteins and epidermal growth factor receptor signaling coordinately regulate cell type specification and cdk inhibitor expression during development. Mol Cell Biol 2007, 27(8):2987-2996. 10.1128/MCB.01685-06, 1899942, 17296729.
54. Morkel M, Wenkel J, Bannister AJ, Kouzarides T, Hagemeier C. An E2F-like repressor of transcription. Nature 1997, 390(6660):567-568. 10.1038/37507, 9403682.
55. Gaubatz S, Wood JG, Livingston DM. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc Natl Acad Sci USA 1998, 95(16):9190-9195. 10.1073/pnas.95.16.9190, 21314, 9689056.
56. Cartwright P, Muller H, Wagener C, Holm K, Helin K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 1998, 17(5):611-623. 10.1038/sj.onc.1201975, 9704927.
57. Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, Lees JA. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci USA 1998, 95(6):2850-2855. 10.1073/pnas.95.6.2850, 19658, 9501179.
58. Giangrande PH, Zhu W, Schlisio S, Sun X, Mori S, Gaubatz S, Nevins JR. A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev 2004, 18(23):2941-2951. 10.1101/gad.1239304, 534654, 15574595.
59. Velasco G, Hube F, Rollin J, Neuillet D, Philippe C, Bouzinba-Segard H, Galvani A, Viegas-Pequignot E, Francastel C. Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Proc Natl Acad Sci USA 2010, 107(20):9281-9286. 10.1073/pnas.1000473107, 2889045, 20439742.
60. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 2002, 296(5570):1132-1136. 10.1126/science.1069861, 12004135.
61. Attwooll C, Oddi S, Cartwright P, Prosperini E, Agger K, Steensgaard P, Wagener C, Sardet C, Moroni MC, Helin K. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J Biol Chem 2005, 280(2):1199-1208.
62. Deshpande AM, Akunowicz JD, Reveles XT, Patel BB, Saria EA, Gorlick RG, Naylor SL, Leach RJ, Hansen MF. PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors. Oncogene 2007, 26(12):1714-1722. 10.1038/sj.onc.1209988, 2691996, 17001316.
63. Trojer P, Cao AR, Gao Z, Li Y, Zhang J, Xu X, Li G, Losson R, Erdjument-Bromage H, Tempst P, et al. L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol Cell 2011, 42(4):438-450. 10.1016/j.molcel.2011.04.004, 3142354, 21596310.
64. Nouspikel T, Hanawalt PC. Impaired nucleotide excision repair upon macrophage differentiation is corrected by E1 ubiquitin-activating enzyme. Proc Natl Acad Sci USA 2006, 103(44):16188-16193. 10.1073/pnas.0607769103, 1621053, 17060614.
65. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
66. Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 2006, 1(2):729-748. 10.1038/nprot.2006.98, 3004291, 17406303.
67. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008, 9(9):R137. 10.1186/gb-2008-9-9-r137, 2592715, 18798982.
68. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11(5):1475-1489. 10.1093/nar/11.5.1475, 325809, 6828386.
69. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74(20):5383-5392. 10.1021/ac025747h, 12403597.
70. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75(17):4646-4658. 10.1021/ac0341261, 14632076.